Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01065597 · ClinicalTrials.gov registry record · Phase 1
Nonconvulsive Electrotherapy: a Proof-of-concept Trial
A Phase 1 study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT01065597 is a Phase 1 study that has completed, run by University of Maryland, College Park. The registered enrollment target is 13 participants.
The verdict
NCT01065597, a Phase 1 study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study involves pilot testing of a modified version of a proven treatment for mental illness. The treatment, electroconvulsive therapy (ECT) is used to treat more than 100,000 Americans yearly. ECT is the most effective treatment for major depression, a disorder that affects approximately 5 to 8 percent of the adult US population yearly. It is also an effective treatment for mania and mixed mood states associated with bipolar disorder and schizoaffective disorder. The aim of ECT is to induce a seizure, which is thought to be responsible for both its therapeutic and its adverse cognitive effects. The proposed modification consists of reducing the ECT electrical stimulus dose below the amount necessary to induce seizures so that adverse cognitive effects, such as confusion and memory problems, are minimized. The investigators intend to determine whether ECT-related cognitive impairment can be reduced without diminishing the therapeutic effect of ECT. In addition to distressing patients, ECT-related cognitive impairment has significant public health consequences. These include increased morbidity and mortality among severely ill individuals who refuse ECT due to concern over its adverse cognitive effects as well as increased falls among the elderly receiving ECT. Elderly patients are far more likely to receive ECT and are also more vulnerable to ECT-related cognitive impairment. They often require hospitalization for ECT and a longer hospital stay with greater spacing of treatments to minimize adverse cognitive effects. The hypothesis driving this research is that electrical brain stimulation applied in the same manner as standard ECT, but at a lower dose, can have therapeutic effects and fewer adverse cognitive effects without inducing seizures. This hypothesis is based on the following: 1) the investigators clinical experience of patients who have improved with ECT despite having only one or no seizure, 2) animal studies showing that electrical brain stimulati
Interventions
- DEVICE Nonconvulsive electrotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01065597
The ClinicalTrials.gov registry entry for NCT01065597 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nonconvulsive electrotherapy is the first listed.
NCT01065597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01065597 about?
NCT01065597 is a clinical study titled "Nonconvulsive Electrotherapy: a Proof-of-concept Trial". This study involves pilot testing of a modified version of a proven treatment for mental illness. The treatment, electroconvulsive therapy (ECT) is used to treat more than 100,000 Americans yearly. ECT is the most effective treatment for major depression, a disorder that affects approximately 5 to 8...
What is the current status of trial NCT01065597?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2010-05. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01065597?
The interventions under investigation include: Nonconvulsive electrotherapy (DEVICE).
Who is sponsoring clinical trial NCT01065597?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.